Literature DB >> 8439222

Oral anticoagulant therapy--50 years later.

J E Ansell1.   

Abstract

The year 1991 marked the 50th anniversary of the first clinical use of oral anticoagulant therapy as a means of preventing thromboembolic disease. Despite long-term physician familiarity with oral anticoagulants, this mode of therapy still suffers from a relatively high-risk/safety profile. This review briefly highlights important historical and pharmacokinetic points of interest but focuses predominantly on aspects of the day-to-day management of anticoagulant therapy aiming to enhance physician performance in this therapeutic milieu. Emphasis is placed on therapeutic monitoring, understanding the prothrombin time, managing complications, and assessing future innovations for the management of a growing population of patients treated with orally administered anticoagulants.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8439222

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-01       Impact factor: 2.300

2.  Costs and effectiveness of a nurse specialist anticoagulant service.

Authors:  F C Taylor; A Gray; H Cohen; L Gaminara; M Ramsay; D Miller
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

3.  Blocking bleeding: reversing anticoagulant therapy.

Authors:  Jack Ansell
Journal:  Nat Med       Date:  2013-04       Impact factor: 53.440

4.  Lacunae in patient knowledge about oral anticoagulant treatment: results of a questionnaire survey.

Authors:  Jisha K Joshua; Naveen Kakkar
Journal:  Indian J Hematol Blood Transfus       Date:  2014-06-13       Impact factor: 0.900

5.  Initiation of warfarin therapy: recommendations and clinical pearls.

Authors:  S Erban
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

6.  A survey of pediatric cardiology nurses' understanding of warfarin therapy.

Authors:  F Newall; L Johnston; P Monagle
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

7.  Advances in the Monitoring of Oral Anticoagulation: Point-of-Care Testing, Patient Self-Monitoring, and Patient Self-Management.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

8.  Prospective alpha allocation in the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.

Authors:  Jungnam Joo; Nancy L Geller; Benjamin French; Stephen E Kimmel; Yves Rosenberg; Jonas H Ellenberg
Journal:  Clin Trials       Date:  2010-08-06       Impact factor: 2.486

9.  An Audit of Management of Patients on Oral Anticoagulant Therapy With International Normalized Ratio (INR) Five or Above.

Authors:  Sandeep Chopra; Naveen Kakkar
Journal:  Indian J Hematol Blood Transfus       Date:  2012-01-31       Impact factor: 0.900

10.  A systematic analysis and comparison of warfarin initiation strategies.

Authors:  Benjamin French; Le Wang; Brian F Gage; Richard B Horenstein; Nita A Limdi; Stephen E Kimmel
Journal:  Pharmacogenet Genomics       Date:  2016-10       Impact factor: 2.089

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.